Generation of recombinant MVA-norovirus: a comparison study of bacterial artificial chromosome- and marker-based systems

BACKGROUND: Recombinant Modified Vaccinia Virus Ankara has been employed as a safe and potent viral vector vaccine against infectious diseases and cancer. We generated recMVAs encoding norovirus GII.4 genotype capsid protein by using a marker-based approach and a BAC-based system. In the marker-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Kugler, Franziska, Drexler, Ingo, Protzer, Ulrike, Hoffmann, Dieter, Moeini, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688233/
https://www.ncbi.nlm.nih.gov/pubmed/31399106
http://dx.doi.org/10.1186/s12985-019-1212-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688233/
https://www.ncbi.nlm.nih.gov/pubmed/31399106
http://dx.doi.org/10.1186/s12985-019-1212-y

Ejemplares similares